LCAT-dependent conversion of preβ1-HDL into α-migrating HDL is severely delayed in hemodialysis patients

Journal of the American Society of Nephrology

Volumn 14, Issue 3, 2003, Pages 732-738

  Miida, Takashi ^a   Miyazaki, Osamu ^b   Hanyu, Osamu ^a   Nakamura, Yuichi ^a   Hirayama, Satoshi ^a   Narita, Ichiei ^a   Gejyo, Fumitake ^a   Ei, Isei ^c   Tasaki, Kazuyuki ^d   Kohda, Yutaka ^e   Ohta, Takashi ^f   Yata, Syogo ^f   Fukamachi, Isamu ^b   Okada, Masahiko ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b DAIICHI PURE CHEMICALS CO LTD   (Japan)

^c Santo Daini Iin   (Japan)

^d Saiseikai Niigata Daini Hospital   (Japan)

^e Shinrakuen Hospital   (Japan)

^f Kido Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PRE BETA1 HIGH DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CATABOLISM; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HEMODIALYSIS; HUMAN; INCUBATION TIME; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE;

EID: 0037372713     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000046962.43220.8A     Document Type: Article

References (41)

1. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697-701, 1974
2. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9: S16-S23, 1998
3. Brunzell JD, Albers JJ, Haas LB, Goldberg AP, Agadoa L, Sherrard DJ: Prevalence of serum lipid abnormalities in chronic hemodialysis. Metabolism 26: 903-910, 1977
4. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H: Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis. Metabolism 40: 1002-1008, 1991
5. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H: Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int 41: 1653-1661, 1992
6. Shoji T, Nishizawa Y, Kawagishi T, Kawasaki K, Taniwaki H, Tabata T, Inoue T, Morii H: Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. J Am Soc Nephrol 9: 1277-1284, 1998
7. Lee DM, Knight-Gibson C, Samuelsson O, Attman PO, Wang CS, Alaupovic P: Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency. Kidney Int 61: 209-218, 2002
8. McLeod R, Reeve CE, Frohlich J: Plasma lipoproteins and lecithin:cholesterol acyltransferase distribution in patients on dialysis. Kidney Int 25: 683-688, 1984
9. Mekki K, Bouchenak M, Lamri M, Remaoun M, Belleville J: Changes in plasma lecithin: cholesterol acyltransferase activity, HDL (2), HDL (3) amounts and compositions in patients with chronic renal failure after different times of hemodialysis. Atherosclerosis 162: 409-417, 2002
10. Reade V, Mezdour H, Reade R, Kandoussi M, Dracon M, Fruchart JC, Cachera C: Neutral-lipid transfers and cholesteryl ester transfer protein in hemodialyzed patients. Am J Nephrol 16: 394-401, 1996
11. Castro GR, Fielding CJ: Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry 27: 25-29, 1988
12. Kawano M, Miida T, Fielding CJ, and Fielding PE: Quantitation of preβ-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid. Biochemistry 32: 5025-5028, 1993
13. Miida T, Yamada T, Yamadera T, Ozaki K, Inano K, Okada M: Serum amyloid A protein generates preβ1 high-density lipoprotein from a-migrating high-density lipoprotein. Biochemistry 38: 16958-16962, 1999
14. Neary RH, Gowland E: The effect of renal failure and haemodialysis on the concentration of free apolipoprotein A-1 in serum and the implications for the catabolism of high-density lipoproteins. Clin Chim Acta 171: 239-245, 1988
15. Duval F, Frommherz K, Atger V, Drüeke T, Lacour B: Influence of end-stage renal failure on concentrations of free apolipoprotein A-1 in serum. Clin Chem 35: 963-966, 1989
16. Miida T, Kawano M, Fielding CJ, Fielding PE: Regulation of the concentration of preβ high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity. Biochemistry 31: 11112-11117, 1992
17. Ishida BY, Albee D, Paigen B: Interconversion of prebetamigrating lipoproteins containing apolipoprotein A-I and HDL. J Lipid Res 31: 227-236, 1990
18. Francone OL, Gurakar A, Fielding C: Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived cholesterol. J Biol Chem 264: 7066-7072, 1989
19. Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res 36: 211-228, 1995
20. Miyazaki O, Kobayashi J, Fukamachi I, Miida T, Bujo H, Saito Y: A new sandwich enzyme immunoassay for measurement of plasma pre-β1-HDL levels. J Lipid Res 41: 2083-2088, 2000
21. Hata Y, Mabuchi H, Saito Y, Itakura H, Egusa G, Ito H, Teramoto T, Tsushima M, Tada N, Oikawa S, Yamada N, Yamashita S, Sakuma N, Sasaki J: Report of the Japan Atherosclerosis Society (JAS) guidelines for diagnosis and treatment of hyperlipidemia in Japanese adults. J Arterioscler Thromb 9: 1-27, 2002
22. Miida T, Nakamura Y, Inano K, Matsuto T, Yamaguchi T, Tsuda T, Okada M: Preβ1-high-density lipoprotein increases in coronary artery disease. Clin Chem 42: 1992-1995, 1996
23. Miida T, Inano K, Yamaguchi T, Tsuda T, Okada M: LpA-I levels do not reflect preβ1-HDL levels in human plasma. Atherosclerosis 133: 221-226, 1997
24. Miida T, Yamaguchi T, Tsuda T, Okada M: High preβ1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol diet. Atherosclerosis 138: 129-134, 1998
25. Miida T, Ozaki: K, Murakami T, Kashiwa T, Yamadera T, Tsuda T, Inano K, Okada M: Preβ1-high-density lipoprotein (preβ1-HDL) concentration can change with low-density lipoproteincholesterol (LDL-C) concentration independent of cholesteryl ester transfer protein (CETP). Clinica Chimica Acta 292: 69-80, 2000
26. Miida T, Sakai K, Ozaki K, Nakamura Y, Yamaguchi T, Tsuda T, Kashiwa T, Murakami T, Inano K, Okada M: Bezafibrate increases preβ1-HDL at the expense of HDL2 in hypertriglyceridemia. Arterioscler Thromb Vasc Biol 20: 2428-2433, 2000
27. Kobori K, Saito K, Ito S, Kotani K, Manabe M, Kanno T: A new enzyme-linked immunosorbent assay with two monoclonal antibodies to specific epitopes measures human lecithin-cholesterol acyltransferase. J Lipid Res 43: 3253-334, 2002
28. Saito K, Kobori K, Hashimoto H, Ito S, Manabe M, Yokoyama S: Epitope mapping for the anti-rabbit cholesteryl ester transfer protein monoclonal antibody that selectively inhibits triglyceride transfer. J Lipid Res 40: 2013-2021, 1999
29. Markwell MA: A new solid-state reagent to iodinate proteins. I: Conditions for the efficient labeling of antiserum. Anal Biochem 125: 427-432, 1982
30. Cheung MC: Distribution of lecithin-cholesterol acyltransferase in normolipidemic and dyslipidemic plasma. Int J Clin Lab Res 23: 30-33, 1993
31. Braschi S, Neville TA, Maugeais C, Ramsamy TA, Seymour R, Sparks DL: Role of the kidney in regulating the metabolism of HDL in rabbits: Evidence that iodination alters the catabolism of apolipoprotein A-I by the kidney. Biochemistry 39: 5441-5449, 2000
32. Brenner BM, Baylis C, Deen WM: Transport of molecules across renal glomerular capillaries. Physiol Rev 56: 502-534, 1976
33. Braschi S, Neville TA-M, Vohl M-C, Sparks DL: Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo. J Lipid Res 40: 522-532, 1999
34. Moestrup SK, Kozyraki R: Cubilin, a high-density lipoprotein receptor. Curr Opin Lipidol 11: 133-140, 2000
35. 2. A Study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem 269: 11572-11577, 1994
36. Francone OL, Royer L, Haghpassand M: Increased preβ-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes. J Lipid Res 37: 1268-1277, 1996
37. Jaari S, van Dijk KW, Olkkonen VM, van der Zee A, Metso J, Havekes L, Jauhiainen M, Ehnholm C: Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): Importance of PLTP in preβ-HDL generation. Comp Biochem Physiol B Biochm Mol Biol 128: 781-792, 2001
38. Jauhiainen M, Metso J, Pahlman R, Blomqvist S, van Tol A, Ehnholm C: Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 268: 4032-4036, 1993
39. von Eckardstein A, Jauhiainen M, Huang Y, Metso J, Langer C, Pussinen P, Wu S, Ehnholm C, Assmann G: Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. Biochim Biophys Acta. 1301: 255-262, 1996
40. Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T, Tabata T, Inoue T, Morii H: High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 48: 820-826, 1995
41. Kimura H, Miyazaki R, Suzuki S, Gejyo F, Yoshida H: Cholesterylester transfer protein as a protective factor against vascular disease in hemodialysis patients. Am J Kidney Dis 38: 70-76, 2001